Table 1 Age (at baseline), IQ, years in education and psychological distress

From: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

 

Chemotherapy ( N =85)

Nonchemotherapy ( N =43)

Control ( N =49)

Age (years)

51.49 (9.57)

58.93 (7.27)

51.90 (6.87)

IQ

109.89 (12.34)

111.05 (11.24)

112.04 (9.14)

Years in education

12.02 (2.60)

11.44 (1.76)

12.63 (2.86)

Menopausal status

 Premenopausal

39 (46%)

7 (16%)

13 (26%)

 Peri/Postmenopausal

46 (54%)

36 (84%)

36 (73%)

HRT use

 Never

18 (39%)

13 (36%)

14 (39%)

 Current

  

15 (42%)

 Past

28 (61%)

23 (64%)

7 (19%)

Above threshold GHQ 12 scores a , b

 T1

46(55%)

26(62%)

8(16%)

 T2

43(51%)

10(24%)

9(18%)

 T3

14(18%)

9 (21%)

12(24%)

  1. aData missing from 1 chemotherapy patient at T1 and T2 and from 7 at T3.
  2. bData missing from one nonchemotherapy patient at each time point.